TP53 and cancer: In summary, a distinction emerged between melanoma and the other types of cancer, both with regard to the sequence contexts targeted by driver mutations, DGAN vs. CGNN sequences, and to the pathways that hosted these mutations, MAP kinase vs. p53-associated signaling pathways.